Anzeige
Mehr »
Login
Samstag, 25.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
389 Leser
Artikel bewerten:
(1)

REVIV3 PROCARE COMPANY: Reviv3 Procare Announces Strong Initial Campaign Results from Mass Market National Advertising Effort

Finanznachrichten News

Campaign Driving Substantial 892% Increase in New Purchase Sales by First-Time Customers

LOS ANGELES, CA / ACCESSWIRE / May 11, 2021 / Reviv3 Procare Company (OTCQB:RVIV), an emerging global e-commerce brand in the premium hair care products industry, today announced strong initial campaign performance results from the Company's first mass market advertising effort launched in late April 2021, aimed at growing direct-to-consumer sales and raising awareness of Reviv3's flagship 3-part hair care system as well as other complementary products.

As compared to the same year-ago period, the campaign has thus far driven a 338% increase in direct-to-consumer channel sales, with an 892% increase in new purchase sales by first-time customers.

The "Beautiful Hair, Beautiful You" campaign is the Company's largest and broadest campaign to date. The national advertising effort targets the Company's core customer base as well as younger consumers through a multi-faceted digital media advertising campaign spanning multiple social media channels, driving targeted sales and new user traffic. The initial campaign is scheduled to continue through May 30, 2021.

"Our first mass market ad campaign has shown substantial performance thus far, notably expanding our high-margin direct-to-consumer business," said Jeff Toghraie, Chairman and Chief Executive Officer of Reviv3 Procare. "We are seeing strong traction in our target demographics, driving new users to the Reviv3 product platform. Given the recurring nature of our product sales, we believe this influx of new users will help to drive a large base of long-term, passionate customers.

"With these positive initial results in hand, we have continued to optimize our target audience and adjust ad spend to increase our reach and effectiveness. Given the success we have seen to-date, we expect to significantly ramp our advertising spend in the coming weeks to capture additional market share. I look forward to providing further updates upon the conclusion of this initial campaign as we strive to create sustainable, long-term value for our shareholders," concluded Toghraie.

About Reviv3 Procare Company

Reviv3 Procare Company (OTCQB:RVIV) is an emerging global e-commerce brand in the $90 billion hair care products industry. The Company is a predominantly direct-to-consumer marketer of premium hair and skincare products under its in-house Reviv3 Procare brand - selling products in the United States, Canada, the European Union and throughout Asia. To learn more, please visit the Company's website at www.reviv3.com.

Forward-Looking Statements

This press release contains a number of forward-looking statements within the meaning of the federal securities laws. The use of words such as "anticipates," "expects," "intends," "plans," "confident that" and "believes," among others, generally identify forward-looking statements.

These forward-looking statements are based on currently available information, and management's beliefs, projections, and current expectations subject to a number of significant risks and uncertainties. Factors that could cause actual results to differ materially from those in the forward-looking statements include, among other things: (i) Reviv3's ability to grow net sales and adjusted EBITDA as anticipated; (ii) our ability to fund our operating expenses (iii) potential difficulties or delays Reviv3 may experience in implementing its cost savings and efficiency initiatives; (iv) Reviv3's ability to compete effectively with other hair and skincare companies (v) the concentration of Reviv3's customers, potentially increasing the negative impact to Reviv3 by changing purchasing or selling patterns (vi) changes in laws or regulations in the United States and/or in other major markets, such as China, in which Reviv3 operates, including, without limitation, with respect to taxes, tariffs, trade policies or product safety, which may increase Reviv3's product costs and other costs of doing business, and reduce Reviv3's earnings. Potential investors are urged to consider these factors carefully in evaluating the forward-looking statements. These forward-looking statements speak only as of the date hereof. Except as required by law, Reviv3 does not assume any obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future.

Investor Contact:
Lucas A. Zimmerman
Senior Vice President
MZ Group - MZ North America
949-259-4987
RVIV@mzgroup.us
www.mzgroup.us

SOURCE: REVIV3 PROCARE COMPANY



View source version on accesswire.com:
https://www.accesswire.com/646313/Reviv3-Procare-Announces-Strong-Initial-Campaign-Results-from-Mass-Market-National-Advertising-Effort

© 2021 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.